Document Detail


Adverse drug reactions resulting in hyperthermia in the intensive care unit.
MedLine Citation:
PMID:  20502177     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyperthermia is frequently seen in the intensive care setting and is associated with significant morbidity and mortality. It is often initially misdiagnosed as fever associated with infection. Atypical presentations of classic syndromes are common. Clinical suspicion is the key to diagnosis. Adverse drug reactions are a frequent culprit. Syndromes include adrenergic "fever," anticholinergic "fever," antidopaminergic "fever," serotonin syndrome, malignant hyperthermia, uncoupling of oxidative phosphorylation, and withdrawal from baclofen. This review describes the pathophysiology of hyperthermia, as distinct from fever, and the physiology, diagnosis, and treatment of serotonin syndrome, neuroleptic malignant syndrome, malignant hyperthermia, and baclofen withdrawal. Much of the available evidence regarding the treatment of these disorders is based on single case reports, case series, or animal models. Therapeutic modalities consist of identification/withdrawal of possible offending agent(s), support directed at lowering temperature and preventing/treating complications, as well as targeted pharmacologic therapy directed at the specific cause. Early recognition and treatment using a multidisciplinary approach are essential to achieve the best possible outcome.
Authors:
Karen J McAllen; David R Schwartz
Related Documents :
11314837 - Life-threatening cardiac failure in a healthy young female with irukandji syndrome.
10092727 - Serotonin syndrome in a child after a single dose of fluvoxamine.
14564517 - Malignant hypertension and cerebral haemorrhage in seckel syndrome.
11718487 - Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional...
2507477 - Post-traumatic headache with scintillating scotoma treated with phenytoin (dilantin).
10885217 - Unusual hand malformations with cardiac defects--a variant of heart--hand syndrome iv.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care medicine     Volume:  38     ISSN:  1530-0293     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-07-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S244-52     Citation Subset:  AIM; IM    
Affiliation:
Department of Pharmacy, Spectrum Health Hospitals, Grand Rapids, MI, USA. karen.mcallen@spectrum-health.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Baclofen / adverse effects
Drug Toxicity / complications*,  diagnosis,  physiopathology,  therapy
Fever / chemically induced*,  diagnosis,  physiopathology,  therapy
Humans
Intensive Care / methods
Intensive Care Units*
Malignant Hyperthermia / diagnosis,  physiopathology,  therapy
Neuroleptic Malignant Syndrome / diagnosis,  physiopathology,  therapy
Serotonin Syndrome / diagnosis,  physiopathology,  therapy
Substance Withdrawal Syndrome / diagnosis,  physiopathology,  therapy
United States
Chemical
Reg. No./Substance:
1134-47-0/Baclofen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the inte...
Next Document:  Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit.